Although they are promising in animal models, their application in human clinical trials for conditions like IPF remains limited due to the complexity of fibrosis and incomplete understanding of HDAC isoform functions [340]. This evidence concerns the gene HDAC9 and idiopathic pulmonary fibrosis.